Axillary management for early invasive breast cancer patients: Who will truly benefit?

BACKGROUND: The implementation of sentinel lymph node biopsy (SLNB) and further completion axillary lymph node dissection (cALND) after positive sentinel lymph nodes (SLNs) on early invasive breast cancer patients should be cautiously tailored. Identifying predictors for SLN and non-sentinel lymph n...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanbiao, Fan, Yan, Jin, Zining, Cui, Mengyao, Yu, Xinmiao, Jin, Feng, Wang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421357/
https://www.ncbi.nlm.nih.gov/pubmed/36046051
http://dx.doi.org/10.3389/fonc.2022.989975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421357/
https://www.ncbi.nlm.nih.gov/pubmed/36046051
http://dx.doi.org/10.3389/fonc.2022.989975

Ejemplares similares